IDH1 and acute myeloid leukemia: ,20,21 FTO has been shown to contribute to oncogenesis in acute myeloid leukemia (AML)22 and R-2-hydroxyglutarate (R-2-HG), a metabolite produced by mutant IDH, inhibits FTO function, limiting aerobic glycolysis in AML.23